Status:
COMPLETED
Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients
Lead Sponsor:
Laval University
Conditions:
Lung Cancer
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The proposed study is a randomized, double-blind, placebo-controlled evaluation if a small dose of IV dexamethasone during induction anesthesia in association to pre and postoperative intercostal nerv...
Detailed Description
This is a study composed by 2 groups of 50 patients undergoing VATS for lung cancer. All subjets will receive intraoperative intercostal nerve block with a maximum dose of 2 mg/kg of bupivacaine with ...
Eligibility Criteria
Inclusion
- resectable stage I and II lung cancer patients submitted to VATS
- american society of anesthesiology Classification (ASA) I or II
Exclusion
- chronic pain;
- chronic analgesic consumption;
- severe renal or liver disease;
- endocrine or mental diseases;
- poorly controlled diabetes;
- allergy to bupivacaine;
- previous thoracotomy;
- systemic use of corticosteroids;
- morbid obesity;
- poor French comprehension precluding completion of the QoR-40 questionnaire;
- patient refusal.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02275702
Start Date
October 1 2014
End Date
December 1 2016
Last Update
August 25 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Universitaire de Cardiologie et de Pneumologie de Québec, IUCPQ
Québec, Canada, G1v 4G5
2
IUCPQ
Québec, Canada, G1V3H8